Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan

Clinical and Experimental Nephrology

Volumn 12, Issue 1, 2008, Pages 53-57

  Iwasa, Yuko ^a   Otsubo, Shigeru ^a   Sugi, Orie ^a   Sato, Keitaro ^a   Asamiya, Yukari ^a   Eguchi, Aya ^a   Iwasaki, Tomihito ^a   Matsuda, Nami ^a   Kikuchi, Kan ^a   Ikebe, Norisato ^a   Miwa, Naoko ^a   Kimata, Naoki ^a   Uchida, Keiko ^a   Uchida, Shigeharu ^b   Nitta, Kosaku ^a   Akiba, Takashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Metro Tokyo Red Cross Cord Blood Bank   (Japan)

Author keywords

Diabetes mellitus; Diabetic nephropathy; End stage kidney disease (ESKD); Hemodialysis; Hepatitis C; Liver chirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IRON;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ERYTHROCYTE COUNT; FEMALE; GROUPS BY AGE; HEMATOCRIT; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON BINDING CAPACITY; JAPAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREVALENCE; SEX DIFFERENCE; THROMBOCYTE COUNT;

ADULT; AGED; BLOOD DONORS; DIABETIC NEPHROPATHIES; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS;

EID: 38549094207     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0005-6     Document Type: Article

References (16)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
2. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36:3-10.
3. Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000;11:1896-1902.
4. Maisonneuve P, Agodoal L, Gellert R et al Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93-9.
5. Kikuchi K, Yoshida T, Kimata N, Sato C, Akiba T. Prevalence of hepatitis E virus infection in regular hemodialysis patients. Ther Apher Dial. 2006;10:193-7.
6. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young E. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 2004;65:2335-42.
7. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36:3-10.
8. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003;42:631-57.
9. An overview of regular dialysis treatment in Japan as of December 31, 2006. Japanese society for dialysis therapy: 2007.
10. Tokyo Metropolitan Blood Center. 2006 annual report of Japanese Red Cross Tokyo Metropolitan Blood Center: Tokyo, Japan, 2006; 1-6.
11. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, Puro V, Casalino C, Ippolito G. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis. 2001;37:1004-10.
12. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis. 2005;45:684-9.
13. Ocak S, Duran N, Kaya H, Emir I. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis. Int J Clin Pract. 2006;60:670-4.
14. Petrides AS. Liver disease and diabetes mellitus. Diabetes Rev. 1994;2:2-18.
15. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:328-33.
16. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly. 2003;133:611-8.